N. Sayınalp

发表

Thrombomodulin and GFC levels in Legg–Calve–Perthes disease

D. Aksoy, M. Aksoy, I. Haznedaroglu, 2008, Hematology.

Thromboprophylaxis in Hip Fracture Surgery: A Pilot Study Comparing Danaparoid, Enoxaparin and Dalteparin

J. Finsterer, V. Kakkar, T. Nakajima, 1999, Pathophysiology of Haemostasis and Thrombosis.

Two common genetic thrombotic risk factors: Factor V Leiden and prothrombin G20210A in adult Turkish patients with thrombosis

Y. Bayraktar, N. Sayınalp, O. Ozcebe, 2001, American journal of hematology.

The comparison of bone marrow kinetics between patients with acute myeloid leukemia and acute promyelocytic leukemia after induction chemotherapy

S. Aksu, I. Haznedaroglu, N. Sayınalp, 2019, Immunopharmacology and immunotoxicology.

Risk factors in central retinal vein occlusion an activated protein C resistance.

N. Sayınalp, D. Kalaycı, D. Gven, 1999, European journal of ophthalmology.

Risk Factors in Central Retinal Vein Occlusion and Activated Protein C Resistance

D. Güven, N. Sayınalp, D. Kalaycı, 1999, European journal of ophthalmology.

Identification of clinical and simple laboratory variables predicting responsible gastrointestinal lesions in patients with iron deficiency anemia

S. Aksu, I. Haznedaroglu, N. Sayınalp, 2010, International journal of medical sciences.

Mitoxantrone-melphalan conditioning regimen for autologous stem cell transplantation in relapsed/refractory lymphoma

S. Aksu, I. Haznedaroglu, N. Sayınalp, 2019, Turkish journal of medical sciences.

The effects of blood group types on the risk of COVID-19 infection and its clinical outcome

S. Ünal, S. Aksu, M. Akova, 2020, Turkish journal of medical sciences.

EUTOS CML prognostic scoring system predicts ELN-based ‘event-free survival’ better than Euro/Hasford and Sokal systems in CML patients receiving front-line imatinib mesylate

S. Aksu, I. Haznedaroglu, N. Sayınalp, 2013, Hematology.

Spinal myeloid sarcoma in two non-leukemic patients.

S. Aksu, I. Haznedaroglu, N. Sayınalp, 2010, Internal medicine.

Local Renin-Angiotensin System in Normal Hematopoietic and Multiple Myeloma-Related Progenitor Cells

S. Aksu, N. Sayınalp, U. Özbek, 2014, Turkish journal of haematology : official journal of Turkish Society of Haematology.

Increased Soluble Selectins as a Reflection of Activated Platelets and Endothelium in Legg-Calve-Perthes Disease

D. Aksoy, M. Aksoy, I. Haznedaroglu, 2014, Journal of pediatric hematology/oncology.

Circulating Thrombopoietin in Clonal Versus Reactive Thrombocytosis

D. Ertuğrul, N. Sayınalp, Ş. Kirazlı, 2002, Hematology.

Evaluation of the Haemostatic System during Ketoacidotic Deterioration of Diabetes mellitus

N. Sayınalp, Ş. Kirazlı, N. Ileri, 1999, Pathophysiology of Haemostasis and Thrombosis.

Protein C Inhibitor and Serum Amyloid a in Immune Thrombocytopaenic Purpura

S. Aksu, N. Sayınalp, Ş. Kirazlı, 2004, The Journal of international medical research.

Copper deficiency with increased hematogones mimicking refractory anemia with excess blasts.

N. Sayınalp, Y. Buyukasik, R. Yılmaz, 2008, Leukemia research.

Over-expression of angiotensin-converting enzyme (CD 143) on leukemic blasts as a clue for the activated local bone marrow RAS in AML

S. Aksu, H. Canpınar, M. Kekıllı, 2006, Leukemia & lymphoma.

Predictive factors for stem cell mobilization failure in multiple myeloma patients: A single center experience.

I. Haznedaroglu, N. Sayınalp, Y. Buyukasik, 2020, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

Bone marrow fibrosis may be an effective independent predictor of the ‘TKI drug response level’ in chronic myeloid leukemia

S. Aksu, I. Haznedaroglu, N. Sayınalp, 2015, Hematology.

Human Ace D/I Polymorphism Could Affect the Clinicobiological Course of COVID-19

I. Haznedaroglu, N. Sayınalp, A. Alp, 2021, Journal of the renin-angiotensin-aldosterone system : JRAAS.

β-Thalassemia Intermedia Associated with Homozygosity for the -87 (C→T) Mutation in a Turkish Family

A. Gürgey, N. Sayınalp, H. Mergen, 2000, Hemoglobin.

Four-Dimensional Echocardiographic Evaluation of Left Ventricular Systolic Functions in Patients with Chronic Myeloid Leukaemia Receiving Tyrosine Kinase Inhibitors

S. Aksu, N. Ozer, I. Haznedaroglu, 2020, Cardiovascular Toxicology.

Unchanged global fibrinolytic capacity during the course of hematopoietic stem cell transplantation

J. Karakaya, S. Aksu, M. Kekıllı, 2006, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Effective Molecular Monitoring and the Proper Management of Pleural Effusion During the First-Line Dasatinib Administration in CML

S. Aksu, I. Haznedaroglu, N. Sayınalp, 2012 .

Event-free Survival in Patients with Chronic Myeloid Leukemia Receiving Front-line Imatinib Mesylate

S. Aksu, I. Haznedaroglu, N. Sayınalp, 2022, Acta Medica.

Massive Life-Threatening Hemorrhages Due to Toxic Oral Intake of 3750 Mg Dabigatran Etexilate As a Suicide Attempt and the Clinical Management

S. Aksu, I. Haznedaroglu, N. Sayınalp, 2014 .

Megakaryocyte-related interleukins in reactive thrombocytosis versus autonomous thrombocythemia.

N. Sayınalp, Ş. Kirazlı, S. Kiraz, 1996, Acta haematologica.

Co-expression of t(15;17) and t(8;21) in a Case of Acute Promyelocytic Leukemia: Review of the Literature

S. Aksu, I. Haznedaroglu, N. Sayınalp, 2013, Turkish journal of haematology : official journal of Turkish Society of Haematology.

YENĠ TANILI AKUT MĠYELOBLASTĠK LÖSEMĠ HASTALARINDA HASTALIK ÖZELLĠKLERĠ VE TEDAVĠ SONUÇLARINI ETKĠLEYEN FAKTÖRLER: TEK MERKEZ DENEYĠMĠ DISEASE CHARACTERISTICS AND FACTORS INFLUENCING TREATMENT RESPONSE IN NEWLY DIAGNOSED ACUTE MYELOBLASTIC LEUKEMIA PATIENTS: A SINGLE CENTER EXPERIENCE

S. Aksu, N. Sayınalp, H. Goker, 2010 .

Local hematopoietic renin-angiotensin system in myeloid versus lymphoid hematological neoplastic disorders

S. Aksu, U. Ozbek, N. Sayınalp, 2013, Journal of the renin-angiotensin-aldosterone system : JRAAS.

Angiotensin-converting enzyme expression of the lymphoma-associated macrophages in the lymph nodes of Hodgkin's disease.

I. Haznedaroglu, N. Sayınalp, O. Ozcebe, 2007, Journal of the National Medical Association.

Efficacy and Feasibility of Allogeneic Hematopoietic Stem‐Cell Transplantation in the Treatment of Refractory Acute Myeloid Leukemia

S. Aksu, I. Haznedaroglu, N. Sayınalp, 2019, Clinical lymphoma, myeloma & leukemia.

Impact of Time Between Induction Chemotherapy and Complete Remission on Survival Outcomes in Patients With Acute Myeloid Leukemia.

S. Aksu, I. Haznedaroglu, N. Sayınalp, 2019, Clinical lymphoma, myeloma & leukemia.

The Impact of Early Versus Late Platelet and Neutrophil Recovery after Induction Chemotherapy on Survival Outcomes of Patients with Acute Myeloid Leukemia

S. Aksu, I. Haznedaroglu, N. Sayınalp, 2019, Turkish journal of haematology : official journal of Turkish Society of Haematology.

Effect of postremission high dose cytarabine-based consolidation chemotherapy before allogenic stem cell transplantation in outcomes of acute myeloid leukemia patients.

S. Aksu, I. Haznedaroglu, N. Sayınalp, 2018, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic hematopoietic stem cell transplantation for acute leukemia patients: a single center experience.

S. Aksu, I. Haznedaroglu, N. Sayınalp, 2013, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

Prophylactic Central Nervous System Irradiation Is Not Indispensable in Adult Patients with Acute Lymphoblastic Leukemia: A Multicenter Retrospective Cohort Study

S. Aksu, A. Ünal, I. Haznedaroglu, 2022, Turkish journal of haematology : official journal of Turkish Society of Haematology.

Endogenous thrombopoietin levels during the clinical management of acute myeloid leukaemia

S. Aksu, I. Haznedaroglu, N. Sayınalp, 2005, Platelets.

Allografting for Bosutinib, Imatinib, Nilotinib, Dasatinib, and Interferon Resistant Chronic Myeloid Leukemia without ABL Kinase Mutation

S. Aksu, N. Sayınalp, O. Ozcebe, 2011, Case reports in hematology.

The Gray-Zone Concept, Suboptimal Response to Imatinib, Shall be Removed from the ELN-CML Recommendations

S. Aksu, I. Haznedaroglu, N. Sayınalp, 2010 .

The factors affecting early death after the initial therapy of acute myeloid leukemia.

S. Aksu, I. Haznedaroglu, N. Sayınalp, 2015, International journal of clinical and experimental medicine.

Original Article The factors affecting early death after the initial therapy of acute myeloid leukemia

S. Aksu, I. Haznedaroglu, N. Sayınalp, 2015 .

Rebound Thrombocytosis following Induction Chemotherapy Is an Independent Predictor of a Good Prognosis in Acute Myeloid Leukemia Patients Attaining First Complete Remission

S. Aksu, I. Haznedaroglu, N. Sayınalp, 2015, Acta Haematologica.

Indications and Outcomes of Splenectomy for Hematological Disorders

S. Aksu, I. Haznedaroglu, N. Sayınalp, 2019, Open medicine.

Acute Lymphoblastic Leukemia Occurring in a Case of Chronic Lymphocytic Leukemia.

N. Sayınalp, M. Benekli, I. Haznedaroğlu, 1997, Hematology.

High frequency of autonomous T-cell proliferation compatible with T-cell large granular lymphocytic leukemia in patients with cytopenia of unknown etiology

S. Aksu, I. Haznedaroglu, N. Sayınalp, 2015, International Journal of Hematology.

Rational use of the PFA-100 device for screening of platelet function disorders and von Willebrand disease

I. Haznedaroglu, N. Sayınalp, Ş. Kirazlı, 2002, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Paget-Schroetter Syndrome Associated with FV:Q506 and Prothrombin 20210A

R. Doğan, A. Gürgey, N. Sayınalp, 1999, Angiology.

The Predictability of Factor V Leiden (FV:Q506) Gene Mutation via Clotting-Based Diagnosis of Activated Protein C Resistance

S. Aksu, A. Gürgey, N. Sayınalp, 2004, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Neutropenic enterocolitis in adult leukemias.

N. Sayınalp, O. Ozcebe, I. Haznedaroğlu, 1997, International journal of hematology.

The Impact of Jak1/Jak2 Inhibitor Ruxolitinib on the Spleen Size and Symptom Burden in Myeloproliferative Diseases

S. Aksu, I. Haznedaroglu, N. Sayınalp, 2016 .

Pharmacobiological Approach for the Clinical Development of Ruxolitinib in Myeloproliferative Neoplasms

S. Aksu, I. Haznedaroglu, N. Sayınalp, 2015, Turkish journal of haematology : official journal of Turkish Society of Haematology.

CD34+ hematopoietic progenitor cell dose as a predictor of engraftment and survival in multiple myeloma patients undergoing autologous stem cell transplantation

S. Aksu, I. Haznedaroglu, N. Sayınalp, 2020, Turkish journal of medical sciences.

Clinical and pathological correlations of marrow PUMA and P53 expressions in myelodysplastic syndromes

S. Aksu, I. Haznedaroglu, N. Sayınalp, 2015, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

Convalescent (immune) plasma treatment in a myelodysplastic COVID-19 patient with disseminated tuberculosis

S. Aksu, I. Haznedaroglu, N. Sayınalp, 2020, Transfusion and Apheresis Science.

Soluble CD23 in systemic lupus erythematosus and scleroderma

N. Sayınalp, S. Kiraz, M. Calguneri, 1996 .

Interleukin‐1 β and interleukin‐6 in clonal versus reactive thrombocytosis

I. Haznedaroglu, N. Sayınalp, Ş. Kirazlı, 1995 .

Failure of yttrium-90 (90Y)-ibritumomab tiuxetan radioimmunotherapy (Zevalin®) with fatal side effects in relapsed/refractory diffuse large B-cell NHL transformed from other lymphomas.

I. Haznedaroglu, N. Sayınalp, D. Çetiner, 2008, Turkish journal of haematology : official journal of Turkish Society of Haematology.

Perianal infections in patients with leukemia

I. Haznedaroglu, N. Sayınalp, S. Dündar, 1998, Diseases of the colon and rectum.

Recombinant human erythropoietin increases platelet aggregation in chronic hemodialysis patients.

N. Sayınalp, Ş. Çaǵlar, Y. Erdem, 1998, Thrombosis research.

An Immune Thrombocytopenic Purpura-Like Picture Preceding Chronic Myelomonocytic Leukemia: A Case Series and Review of the Literature

S. Aksu, I. Haznedaroglu, N. Sayınalp, 2014 .

ENHANCED TISSUE FACTOR PATHWAY INHIBITOR RESPONSE AS A DEFENSE MECHANISM AGAINST ONGOING LOCAL MICROVASCULAR EVENTS OF LEGG-CALVE-PERTHES DISEASE

D. Aksoy, M. Aksoy, I. Haznedaroglu, 2005, Pediatric hematology and oncology.

Sole Infrequent Karyotypic Aberration Trisomy 6 in a Patient with Acute Myeloid Leukemia and Breast Cancer in Remission

S. Aksu, I. Haznedaroglu, N. Sayınalp, 2017, Turkish journal of haematology : official journal of Turkish Society of Haematology.

The clinical course of COVID-19 in hematopoietic stem cell transplantation (HSCT) recipients

S. Aksu, I. Haznedaroglu, N. Sayınalp, 2021, Turkish journal of medical sciences.

Cytokines in Behçet's disease.

N. Sayınalp, Ş. Kirazlı, O. Ozcebe, 1996, The Journal of rheumatology.

Mature ovarian teratoma as a possible cause of fever and clinical exacerbation in Behçet's disease: a case report

A. Oto, D. Ertoy, N. Sayınalp, 2001, Modern rheumatology.

Renin angiotensin system genes are biomarkers for personalized treatment of acute myeloid leukemia with Doxorubicin as well as etoposide

A. Gure, I. Haznedaroglu, N. Sayınalp, 2020, PloS one.

Molecular Management of Chronic Lymphocytic Leukemia : Towards a Chemotherapy-Free Approach

I. Haznedaroglu, N. Sayınalp, 2016 .

Ibrutinib: From Molecule to Medicine

O. Ayyıldız, F. Şahin, G. Saydam, 2014 .

The Impact of Eltrombopag Administration on the Clinical Course of Severe Refractory Fatal Acquired Aplastic Anemia

S. Aksu, I. Haznedaroglu, N. Sayınalp, 2013, Turkish journal of haematology : official journal of Turkish Society of Haematology.

YENĠ TANILI ERĠġKĠN AKUT LENFOBLASTĠK LÖSEMĠ HASTALARINDA TOTAL SAĞKALIMI ETKĠLEYEN FAKTÖRLER THE FACTORS INFLUENCING OVERALL SURVIVAL IN NEWLY DIAGNOSED ADULT ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS

S. Aksu, N. Sayınalp, H. Goker, 2011 .

Long-Term Sustained Hemorrhage Due to Bone Marrow Biopsy Successfully Treated With Topical Ankaferd Hemostat in a Bleeding-Prone Patient With Secondary Amyloidosis

S. Aksu, I. Haznedaroglu, N. Sayınalp, 2013, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Unchanged global fibrinolytic capacity despite increased factor VIIa activity in Behçet's disease: evidence of a prethrombotic state

N. Sayınalp, Ş. Kirazlı, D. Özatlı, 2001, Rheumatology International.

Efficacy of eltrombopag in thrombocytopenia after hematopoietic stem celltransplantation.

S. Aksu, I. Haznedaroglu, N. Sayınalp, 2022, Turkish journal of medical sciences.

Eculizumab before and after allogeneic hematopoietic stem cell transplantation in a patient with paroxysmal nocturnal hemoglobinuria.

S. Aksu, I. Haznedaroglu, N. Sayınalp, 2011, Turkish journal of haematology : official journal of Turkish Society of Haematology.

Plasma basic fibroblast growth factor and bone marrow fibrosis in clonal myeloproliferative disorders.

S. Aksu, N. Sayınalp, Ş. Kirazlı, 2004, Clinical and laboratory haematology.

Clinicopathological associations of acquired erythroblastopenia.

S. Aksu, I. Haznedaroglu, N. Sayınalp, 2015, International journal of clinical and experimental medicine.

Plasma Thrombopoietin in Patients With Cavernous Transformation of the Portal Vein

Y. Bayraktar, N. Sayınalp, Ş. Kirazlı, 2002, International journal of hematology.

Concomitant renal cell carcinoma and lymphoid malignancies: a case series of five patients and review of the literature

N. Sayınalp, O. Ozcebe, Y. Buyukasik, 2010, Medical oncology.

Unclassifiable non-CML classical myeloproliferative diseases with microcytosis: findings indicating diagnosis of polycythemia vera masked by iron deficiency

S. Aksu, I. Haznedaroglu, N. Sayınalp, 2019, Turkish journal of medical sciences.

Efficacy and Safety of Ibrutinib Therapy in Patients with Chronic Lymphocytic Leukemia: Retrospective Analysis of Real-Life Data

G. Saydam, B. Ferhanoğlu, A. Ünal, 2021, Turkish journal of haematology : official journal of Turkish Society of Haematology.

Effects of interferon-α2a treatment on serum levels of tumor necrosis factor-α, tumor necrosis factor-α2 receptor, interleukin-2, interleukin-2 receptor, and E-selectin in Behçet's disease

N. Sayınalp, Ş. Kirazlı, A. Kosar, 1999, Rheumatology International.

Effects of interferon-alpha2a treatment on serum levels of tumor necrosis factor-alpha, tumor necrosis factor-alpha2 receptor, interleukin-2, interleukin-2 receptor, and E-selectin in Behçet's disease.

N. Sayınalp, Ş. Kirazlı, A. Kosar, 1999, Rheumatology international.

Local umbilical cord blood renin–angiotensin system

S. Aksu, Y. Beyazit, I. Haznedaroglu, 2005, Annals of Hematology.

Circulating thrombomodulin as a molecular marker of endothelium damage in renal transplant recipients.

Ç. Turgan, N. Sayınalp, Ş. Kirazlı, 1996, Nephron.

Effect of platelet count on secretion capacity: formulization and use of the formulae for evaluation of platelet secretion in thrombocytopenic patients

I. Haznedaroglu, N. Sayınalp, O. Ozcebe, 2008, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Plasma Thrombospondin in Immune Thrombocytopenic Purpura

N. Sayınalp, Ş. Kirazlı, A. Kosar, 2002, The Journal of international medical research.

Extramedullary plasmacytomas of the thyroid and pericardium as initial presentation of multiple myeloma

S. Aksu, I. Haznedaroglu, N. Sayınalp, 2008, Annals of Hematology.

Allogeneic Hematopoietic Stem-Cell Transplantation Improves Disease-Free Survival Compared to Pediatric-Inspired Berlin-Frankfurt-Münster Chemotherapy in Adult Acute Lymphoblastic Leukemia.

S. Aksu, I. Haznedaroglu, N. Sayınalp, 2021, Clinical lymphoma, myeloma & leukemia.

Cytogenetic anomalies in Multiple Myeloma patients:A single center study.

S. Aksu, I. Haznedaroglu, N. Sayınalp, 2019, Genetics & Applications.

Penile gangrene in lung cancer.

M. Arıcı, N. Sayınalp, O. Ozcebe, 1997, Postgraduate medical journal.

Comparison of bortezomibcyclophosphamide- dexamethasone versus bortezomib-dexamethasone based regimens in newly diagnosed multiple myeloma patients

S. Aksu, I. Haznedaroglu, N. Sayınalp, 2020, Hematology reports.

Comparison of bortezomib- cyclophosphamide-dexametha- sone versus bortezomib-dex- amethasone based regimens in newly diagnosed multiple myeloma patients

S. Aksu, N. Sayınalp, H. Goker, 2020 .

Comparison of Myeloablative Versus Reduced-Intensity Conditioning Regimens for Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia: A Cohort Study

S. Aksu, I. Haznedaroglu, N. Sayınalp, 2019, Turkish journal of haematology : official journal of Turkish Society of Haematology.

Renin-angiotensin system expression in the K562 human erythroleukaemic cell line

S. Aksu, Y. Beyazit, I. Haznedaroglu, 2007, Journal of the renin-angiotensin-aldosterone system : JRAAS.

Comparison of Myelodysplastic Syndrome Prognostic Scoring Systems

S. Aksu, I. Haznedaroglu, N. Sayınalp, 2016, Turkish journal of haematology : official journal of Turkish Society of Haematology.

Long-term results of allogeneic peripheral blood hematopoietic stem cell transplantation for severe aplastic anemia.

S. Aksu, I. Haznedaroglu, N. Sayınalp, 2021, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

Evaluation of the Survival Outcomes of Multiple Myeloma Patients According to Their Plasmacytoma Presentation at Diagnosis

S. Aksu, I. Haznedaroglu, N. Sayınalp, 2019, Turkish journal of haematology : official journal of Turkish Society of Haematology.

Blood collection in strong acidic citrate anticoagulant for the determination of urokinase-like plasminogen activator.

N. Sayınalp, Ş. Kirazlı, O. Ozcebe, 1995, Thrombosis research.

Enhanced Expression of the Local Haematopoietic Bone Marrow Renin-Angiotensin System in Polycythemia Rubra Vera

S. Aksu, H. Canpınar, Y. Beyazit, 2005, The Journal of international medical research.

The Prognosis of Adult Burkitt’s Cell Leukemia in Real-Life Clinical Practice

S. Aksu, I. Haznedaroglu, N. Sayınalp, 2016, Turkish journal of haematology : official journal of Turkish Society of Haematology.

Soluble platelet glycoprotein V in distinct disease states of pathological thrombopoiesis.

S. Aksu, Y. Beyazit, N. Sayınalp, 2008, Journal of the National Medical Association.

Bone Marrow and Peripheral Blood C-kit Ligand Concentrations in Patients with Thrombocytosis and Thrombocytopenia

N. Sayınalp, Ş. Kirazlı, O. Ozcebe, 2003, Hematology.

Agranulocytosis, Plasmacytosis, and Thrombocytosis Followed by a Leukemoid Reaction Due to Acute Acetaminophen Toxicity

I. Haznedaroglu, N. Sayınalp, S. Dündar, 1996, The Annals of pharmacotherapy.

Megakaryocytopoietic cytokines in autoimmune thrombocytopenic purpura

I. Haznedaroglu, N. Sayınalp, Ş. Kirazlı, 1995, American journal of hematology.

Soluble Thrombomodulin and Fibrinolysis in Behçet’s Disease

I. Haznedaroglu, N. Sayınalp, Ş. Kirazlı, 1996 .

Prolonged viral shedding in a lymphoma patient with COVID-19 infection receiving convalescent plasma

S. Aksu, N. Sayınalp, Ö. Uzun, 2020, Transfusion and Apheresis Science.

Strain Imaging by Speckle Tracking for the Assessment of Diastolic Dysfunction in Beta-Thalassemia Major Patients

E. Karabulut, N. Ozer, S. Unal, 2021 .

The Factors Affecting Early Death in Newly Diagnosed APL Patients

S. Aksu, I. Haznedaroglu, N. Sayınalp, 2019, Open medicine.

Clinical features and outcomes of 49 Turkish patients with acute promyelocytic leukemia who received ATRA and anthracyclines (PETHEMA protocol) therapy.

S. Aksu, I. Haznedaroglu, N. Sayınalp, 2010, Leukemia research.

Dasatinib-Induced Tumor Lysis Syndrome and Following Hematologic Remission in Fibrotic Blastic Crisis of CML

S. Aksu, I. Haznedaroglu, N. Sayınalp, 2010 .

Evaluation of Prognostic Significance of İnternational Scoring System According to Glomerular Filtration Rate in Newly Diagnosed Multiple Myeloma Patients Eligible for Autologous Stem Cell Transplantation.

S. Aksu, I. Haznedaroglu, N. Sayınalp, 2020, Turkish journal of haematology : official journal of Turkish Society of Haematology.

Mean platelet volume, platelet count and platelet dimensional width during hemodialysis.

N. Sayınalp, O. Ozcebe, S. Dündar, 1997, Thrombosis Research.

Piebaldism associated with congenital dyserythropoietic anemia type II (HEMPAS)

D. Ertuğrul, S. Köklü, N. Sayınalp, 2002, American journal of hematology/oncology.

Erythropoiesis: Case Report: Congenital Dyserythropoietic Anemia Type II in a Woman Presenting with Jaundice, Anemia, and Splenomegaly.

I. Haznedaroglu, N. Sayınalp, H. Abalı, 1999, Hematology.

Changes in vascular endothelial growth factor, angiopoietins, and Tie-2 levels with G-CSF stimulation in healthy donors

S. Aksu, I. Haznedaroglu, N. Sayınalp, 2009, Annals of Hematology.

Generic Imatinib Mesylate is as Effective as Original Glivec in the Clinical Management of CML

S. Aksu, I. Haznedaroglu, N. Sayınalp, 2015 .

Expression Profiles of the Individual Genes Corresponding to the Genes Generated by Cytotoxicity Experiments with Bortezomib in Multiple Myeloma

S. Aksu, M. Ghasemi, I. Haznedaroglu, 2016, Turkish journal of haematology : official journal of Turkish Society of Haematology.

Thrombosis and Bleeding in Philadelphia Negative Myeloproliferative Neoplasia: Incidences and Risk Factors

I. Haznedaroglu, N. Sayınalp, Y. Buyukasik, 2019, Acta Medica.

The impact of JAK/STAT inhibitor ruxolitinib on the genesis of lymphoproliferative diseases

S. Aksu, I. Haznedaroglu, N. Sayınalp, 2019, Turkish journal of medical sciences.

Management of humoral secondary immunodeficiency in hematological malignancies and following hematopoietic stem cell transplantation: Regional perspectives.

N. Sayınalp, R. El Fakih, F. Nasr, 2023, Leukemia research.

Fibrinolytic system in plasma and pleural fluid in malignant pleural mesothelioma.

S. Emri, N. Sayınalp, S. Dündar, 1996, Thrombosis research.

Transformation of adult myelodysplastic syndrome-refractory anemia to acute T-cell lymphoblastic leukemia.

N. Sayınalp, O. Ozcebe, Y. Buyukasik, 2009, Journal of the National Medical Association.

Stenotrophomonas maltophilia infection of the central venous catheter and lysis of an old thrombosis in a post-bone marrow transplantation child: Implications in the fibrinolytic process

D. Gür, D. Uçkan, N. Sayınalp, 2007, Scandinavian journal of infectious diseases.

Chemotherapy and imatinib‐induced molecular remission in lymphoid blast crisis after 20 years of “untreated” chronic myeloid leukemia

N. Sayınalp, O. Ozcebe, D. Çetiner, 2007, American journal of hematology.

Nasal Natural Killer/T-cell Lymphoma with Skin, Eye, and Peroneal Nerve Involvement

N. Sayınalp, B. Uz, A. Üner, 2012, Turkish journal of haematology : official journal of Turkish Society of Haematology.

Over-Expression of the Local Bone Marrow Renin-Angiotensin System in Acute Myeloid Leukemia.

S. Aksu, I. Haznedaroglu, N. Sayınalp, 2005 .

Exploring the Distribution and Prognostic Effect of the ABO Blood Types of COVID-19 Patients During Delta and Omicron Waves: A Case Control Study

I. Haznedaroglu, N. Sayınalp, A. Inkaya, 2023, Acta medica.

Hyper-CVAD Regimen in Routine Management of Adult Acute Lymphoblastic Leukemia: A Retrospective Multicenter Study

S. Aksu, I. Haznedaroglu, N. Sayınalp, 2013, Acta Haematologica.

Serum Immunoglobulin E and Soluble CD23 in Patients with Graves' Disease

T. Erbas, N. Sayınalp, Ş. Kirazlı, 1994, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

Rebound Thrombocytosis following Induction Chemotherapy Is an Independent Predictor of a Good Prognosis in Acute Myeloid Leukemia Patients Attaining First Complete Remission

S. Aksu, I. Haznedaroglu, N. Sayınalp, 2015, Acta Haematologica.

Biphenotypic acute leukemia treated with acute myeloid leukemia regimens: a case series.

N. Sayınalp, O. Ozcebe, Y. Buyukasik, 2009, Journal of the National Medical Association.

A single-center experience of haploidentical stem cell transplantation in hematological malignancies

I. Haznedaroglu, N. Sayınalp, Y. Büyükaşık, 2022, Turkish journal of medical sciences.